Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.
Before a recommendation for antimalarial drug use in pregnancy is made, it is essential that we understand the potential risks involved and have mechanisms in place to monitor risk during treatment. This requires data on drug disposition during pregnancy and potential toxicological liabilities to th...
Main Authors: | Ward, SA, Sevene, E, Hastings, I, Nosten, F, Mcgready, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Antimalarial drugs in pregnancy: a review.
by: Nosten, F, et al.
Published: (2006) -
Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.
by: Nosten, F, et al.
Published: (1990) -
Clinical pharmacokinetics of antimalarial drugs.
by: White, N
Published: (1985) -
The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy.
by: Mcgready, R, et al.
Published: (2002) -
Pharmacovigilance of antimalarial treatment in Africa: is it possible?
by: Staedke Sarah G, et al.
Published: (2006-06-01)